What is the appropriate cimetidine dosing regimen for an adult with gastro‑esophageal reflux disease, including adjustments for symptom severity and impaired renal function?

Cimetidine Dosing for GERD

For erosive GERD, use cimetidine 1600 mg daily in divided doses (800 mg twice daily or 400 mg four times daily) for 12 weeks, as this is the FDA-approved regimen for endoscopically-confirmed erosive esophagitis 1.

Important Context: Cimetidine is Not First-Line Therapy

Before discussing dosing, recognize that cimetidine and other H2-receptor antagonists are inferior to proton pump inhibitors (PPIs) for GERD treatment. Current guidelines strongly recommend PPIs as first-line therapy because they are significantly more effective at healing esophagitis and controlling symptoms 2, 3, 4. H2-receptor antagonists like cimetidine should be reserved for:

• Step-down therapy after PPI optimization
• On-demand symptom relief (due to rapid onset)
• Patients who cannot tolerate PPIs
• Adjunctive nighttime dosing in select cases

Standard Dosing Regimens

For Erosive Esophagitis (Endoscopically Confirmed)

• 1600 mg daily in divided doses 1:
  • 800 mg twice daily (preferred for convenience and compliance)
  • OR 400 mg four times daily (with meals and at bedtime)
• Duration: 12 weeks maximum (use beyond 12 weeks not established) 1
• Healing rates: 45-67% at 6-12 weeks 1

For Symptomatic GERD Without Erosions

• 400 mg twice daily for symptom control 5, 6
• Alternative: 800 mg at bedtime 7
• Duration: 2-12 weeks depending on response

On-Demand Therapy

• 200 mg as needed for breakthrough symptoms 6
• Can be taken up to 3 times daily with at least 2 hours between doses
• Useful for rapid symptom relief due to faster onset than PPIs

Renal Impairment Adjustments

For severe renal impairment (CrCl <30 mL/min):

• 300 mg every 12 hours 1, 8
• May increase frequency to every 8 hours if needed, but use caution
• Use the lowest frequency compatible with adequate response
• Time doses to coincide with end of hemodialysis in dialysis patients 1

For moderate renal impairment: Consider dose reduction or extended intervals, though specific guidance is limited in the FDA label.

With concurrent liver impairment: Further dose reductions may be necessary 1.

Clinical Considerations and Pitfalls

Why These Doses Are Suboptimal

The evidence shows cimetidine achieves only modest healing rates (60-67% at 12 weeks) compared to PPIs (>80% at 8 weeks) 1, 7, 9. Studies demonstrate no significant difference between 800 mg and 1600 mg daily regimens 7, 9, suggesting a ceiling effect in efficacy.

Drug Interactions

Cimetidine significantly inhibits cytochrome P450 metabolism 1, 10. This creates clinically important interactions with:

• Warfarin
• Phenytoin
• Theophylline
• Benzodiazepines
• Many other medications

If drug interactions are a concern, consider switching to ranitidine or famotidine, which have less interaction potential 10.

Tolerance Development

H2-receptor antagonists develop tachyphylaxis (tolerance) with continuous use, particularly at higher doses 10. This makes them poorly suited for long-term maintenance therapy. The effect diminishes over weeks to months of continuous administration.

Antacid Interference

Do not administer cimetidine simultaneously with antacids, as they interfere with absorption 1. Separate administration by at least 1-2 hours.

When to Abandon Cimetidine

If symptoms persist after 12 weeks at maximum doses, switch to PPI therapy rather than continuing cimetidine 2, 4. The patient has failed H2-receptor antagonist therapy and requires more potent acid suppression.

Practical Algorithm

1. Confirm GERD diagnosis (typical symptoms or endoscopic findings)
2. Assess renal function before initiating therapy
3. Start 800 mg twice daily (or 400 mg QID if compliance concerns)
4. Reassess at 4-6 weeks:
   • If improved: Continue for total 12 weeks
   • If no improvement: Switch to PPI therapy
5. After 12 weeks:
   • If healed: Consider step-down to 400 mg twice daily or on-demand therapy
   • If not healed: Switch to PPI therapy
6. For maintenance: 400 mg at bedtime, though evidence for efficacy is weak 7

Elderly Patients

While the FDA label notes that elderly patients may have delayed elimination 10, specific dose adjustments are not mandated unless renal function is impaired. Monitor for adverse effects and adjust based on renal function rather than age alone.